Private limited company · Bree · incorporated on 12/11/2019
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 278,0 k € | +105.0% | 135,6 k € | +393.0% | 27,5 k € | -35.5% | 42,7 k € | +26.2% | 33,8 k € | -64.1% | 94,0 k € | |
| EBITDA | 147,9 k € | +88.4% | 78,5 k € | +323.2% | 18,5 k € | -56.2% | 42,4 k € | +47.4% | 28,7 k € | -49.2% | 56,6 k € | |
| Operating profit | 127,6 k € | +81.3% | 70,4 k € | +368.7% | 15,0 k € | -61.3% | 38,8 k € | +54.0% | 25,2 k € | -54.1% | 55,0 k € | |
| Profit/loss | 91,0 k € | +84.3% | 49,4 k € | +385.6% | 10,2 k € | -65.1% | 29,1 k € | +22.2% | 23,8 k € | -39.9% | 39,6 k € | |
| Equity | 146,0 k € | +165.6% | 55,0 k € | +885.5% | 5,6 k € | 0.0% | 5,6 k € | -88.0% | 46,5 k € | +9.0% | 42,6 k € | |
| Total assets | 407,8 k € | +9.7% | 371,6 k € | +112.1% | 175,2 k € | +80.9% | 96,8 k € | +14.6% | 84,5 k € | +15.3% | 73,2 k € | |
| Cash | 29,6 k € | +52.6% | 19,4 k € | -18.4% | 23,7 k € | -53.4% | 51,0 k € | +92.5% | 26,5 k € | +5.9% | 25,0 k € | |
| Debts | 259,8 k € | -15.9% | 308,8 k € | +84.8% | 167,1 k € | +84.5% | 90,6 k € | +139.2% | 37,9 k € | +24.6% | 30,4 k € | |
Private limited company profitable and well capitalised. Cash position rising (+52.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
INTIBIO is a Private limited company incorporated in 2019. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Bree.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette